Targeted delivery of plasmid DNA complexed with galactosylated poly(L- lysine)

Journal of Controlled Release

Volumn 53, Issue 1-3, 1998, Pages 301-310

  Hashida, Mitsuru ^a   Takemura, Shigeo ^a   Nishikawa, Makiya ^a   Takakura, Yoshinobu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Galactosylated poly(L lysine); Gene therapy; Hepatic uptake; Pharmacokinetics; Plasmid DNA

Indexed keywords

PLASMID DNA; POLYLYSINE;

CANCER CELL CULTURE; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; GENE EXPRESSION; GENE THERAPY; PRIORITY JOURNAL; REPORTER GENE;

ANIMALS; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DNA; DRUG CARRIERS; GALACTOSE; HUMANS; LIVER; MALE; MICE; PARTICLE SIZE; PLASMIDS; POLYLYSINE; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0032580535     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(97)00263-0     Document Type: Conference Paper

References (44)

1. Cordier L., Duffour M.T., Sabourin J.C., Lee M.G., Cabannes J., Ragot T., Perricaudet M., Haddada H. Complete recovery of mice from a pre-established tumor by direct intratumoral delivery of an adenovirus vector harboring the murine IL-2 gene. Gene Ther. 2:1995;16-21.
2. Toloza E.M., Hunt K., Swisher S., McBride W., Lau R., Pang S., Rhoades K., Drake T., Belldegrun A., Glaspy J., Economou J.S. In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector. Cancer Gene Ther. 3:1996;11-17.
3. Caruso M., Pham-Nguyen K., Kwong Y.L., Xu B., Kosai K., Finegold M., Woo S.L.C., Chen S.H. Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma. Proc. Natl. Acad. Sci. USA. 93:1996;11302-11306.
4. Ido A., Nakata K., Kato Y., Nakao K., Murata K., Fujita M., Ishii N., Tamaoki T., Shiku H., Nagataki S. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human α-fetoprotein gene promoter. Cancer Res. 55:1995;3105-3109.
5. Wei M.X., Tamiya T., Hurford R.K. Jr., Boviatsis E.J., Tepper R.I., Chiocca E.A. Enhancement of interleukin-4-mediated tumor regression in athymic mice by in situ retroviral gene transfer. Hum. Gene Ther. 6:1995;437-443.
6. Mahato R.I., Takakura Y., Hashida M. Nonviral vectors for in vivo gene therapy: physicochemical and pharmacokinetic considerations. Crit. Rev. Ther. Drug Carrier Syst. 14:1997;85-124.
7. Zhu N., Liggitt D., Liu Y., Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science. 261:1993;209-211.
8. Liu Y., Liggitt D., Zhong W., Tu G., Gaensler K., Debs R. Cationic liposome-mediated intravenous gene delivery. J. Biol. Chem. 270:1995;24864-24870.
9. Wu G.Y., Wu C.H. Receptor-mediated gene delivery and expression in vivo. J. Biol. Chem. 263:1988;14621-14624.
10. Perales J.C., Ferkol T., Beegen H., Ratnoff O.D., Hanson R.W. Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-mediated uptake. Proc. Natl. Acad. Sci. USA. 91:1994;4086-4090.
11. Wu G.Y., Wu C.H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 262:1987;4429-4432.
12. Wagner E., Zenke M., Cotton M., Beug H., Birnstiel M.L. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc. Natl. Acad. Sci. USA. 87:1990;3410-3414.
13. Huckett B., Ariatti M., Hawtrey A.O. Evidence for targeted gene transfer by receptor-mediated endocytosis. Stable expression following insulin-directed entry of neo into HepG2 cells. Biochem. Pharmacol. 40:1990;253-263.
14. Takakura Y., Hashida M. Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution. Pharm. Res. 13:1996;820-831.
15. Nishikawa M., Takakura Y., Hashida M. Pharmacokinetic evaluation of polymeric carriers. Adv. Drug Deliv. Rev. 21:1996;135-155.
16. Hashida M., Kato A., Takakura Y., Sezaki H. Disposition pharmacokinetics of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate, in the rat. Drug Metab. Dispos. 12:1984;492-499.
17. Atsumi R., Endo K., Kakutani T., Takakura Y., Hashida M., Sezaki H. Disposition characteristics of mitomycin C-dextran conjugate in normal and tumor-bearing muscles of rabbits. Cancer Res. 47:1987;5546-5551.
18. Takakura Y., Takagi A., Hashida M., Sezaki H. Disposition and tumor localization of mitomycin C-dextran conjugates in mice. Pharm. Res. 4:1987;293-300.
19. Nishikawa M., Kamijo A., Fujita T., Takakura Y., Sezaki H., Hashida M. Synthesis and pharmacokinetics of a new liver-specific carrier, glycosylated carboxymethyl-dextran, and its application to drug targeting. Pharm. Res. 10:1993;1253-1261.
20. Hashida M., Hirabayashi H., Nishikawa M., Takakura Y. Targeted delivery of drugs and proteins to the liver via receptor-mediated endocytosis. J. Control. Release. 46:1997;129-137.
21. Takakura Y., Fujita T., Hashida M., Maeda H., Sezaki H. Control of pharmaceutical properties of soybean trypsin inhibitor by conjugation with dextran II: biopharmaceutical and pharmacological properties. J. Pharm. Sci. 78:1989;219-222.
22. Takakura Y., Fujita T., Hashida M., Sezaki H. Disposition characteristics of macromolecules in tumor-bearing mice. Pharm. Res. 7:1990;339-346.
23. Fujita T., Yasuda Y., Takakura Y., Hashida M., Sezaki H. Alteration of biopharmaceutical properties of drugs by their conjugation with water-soluble macromolecules: uricase-dextran conjugate. J. Control. Release. 11:1990;149-156.
24. Fujita T., Nishikawa M., Tamaki C., Takakura Y., Hashida M., Sezaki H. Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and poly-saccharide derivatives. J. Pharmacol. Exp. Ther. 263:1992;971-978.
25. Takakura Y., Fujita T., Furitsu H., Nishikawa M., Sezaki H., Hashida M. Pharmacokinetics of succinylated proteins and dextran sulfate in mice: Implications for hepatic targeting of protein drugs by direct succinylation via scavenger receptors. Int. J. Pharm. 105:1994;19-29.
26. Nishikawa M., Ohtsubo Y., Ohno J., Fujita T., Koyama Y., Takakura Y., Hashida M., Sezaki H. Pharmacokinetics of receptor-mediated hepatic uptake of glycosylated albumin in mice. Int. J. Pharm. 85:1992;75-85.
27. Nishikawa M., Hirabayashi H., Takakura Y., Hashida M. Design for cell-specific targeting of proteins utilizing sugar-recognition mechanism: effect of molecular weight of proteins on targeting efficiency. Pharm. Res. 12:1995;209-214.
28. Nishikawa M., Miyazaki C., Yamashita F., Takakura Y., Hashida M. Galactosylated proteins are recognized by the liver according to the surface density of galactose moieties. Am. J. Physiol. 268:1995;G849-G856.
29. Hirabayashi H., Nishikawa M., Takakura Y., Hashida M. Development and pharmacokinetics of galactosylated poly-L-glutamic acid as a biodegradable carrier for liver-specific drug delivery. Pharm. Res. 13:1996;880-884.
30. Kawabata K., Takakura Y., Hashida M. The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake. Pharm. Res. 12:1995;825-830.
31. Yoshida M., Mahato R.I., Kawabata K., Takakura Y., Hashida M. Disposition characteristics of plasmid DNA in the single-pass rat liver perfusion system. Pharm. Res. 13:1996;599-603.
32. Mahato R.I., Kawabata K., Takakura Y., Hashida M. In vivo disposition characteristics of plasmid DNA complexed with cationic liposomes. J. Drug Targeting. 3:1995;149-157.
33. Mahato R.I., Kawabata K., Nomura T., Takakura Y., Hashida M. Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes. J. Pharm. Sci. 84:1995;1267-1271.
34. K. Sambrook, E.F. Fritsch, T. Maniatis, Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Lab. Press, Plainview, NY, 1989.
35. Kaliss N., Pressman D. Plasma and blood volumes of mouse organs, as determined with radioactive iodoproteins. Proc. Soc. Exp. Biol. Med. 75:1950;16-20.
36. Friedman J.J. Organ plasma volume of normal unanesthetized mice. Proc. Soc. Exp. Biol. Med. 88:1955;323-325.
37. Bischoff K.B., Dedrick R.L., Zaharko D.S., Longstreth J.A. Methotrexate pharmacokinetics. J. Pharm. Sci. 60:1971;1128-1133.
38. Perales J.C., Ferkol T., Molas M., Hanson R.W. An evaluation of receptor-mediated gene transfer using synthetic DNA-ligand complexes. Eur. J. Biochem. 226:1994;255-266.
39. Ferkol T., Perales J.C., Mularo F., Hanson R.W. Receptor-mediated gene transfer into macrophages. Proc. Natl. Acad. Sci. USA. 93:1996;101-105.
40. Erbacher P., Roche A.C., Monsigny M., Midoux P. Glycosylated polylysine/DNA complexes: gene transfer efficiency in relation with the size and the sugar substitution level of glycosylated polylysines and with the plasmid size. Bioconjugate Chem. 6:1995;401-410.
41. Erbacher P., Bousser M.-T., Raimond J., Monsigny M., Midoux P., Roche A.C. Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages. Hum. Gene Ther. 7:1996;721-729.
42. Wisse E., De Zanger R.B., Charels K., Van Der Smissen P., McCuskey R.S. The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology. 5:1985;683-692.
43. Blomhoff R., Blomhoff H.K., Tolleshaug H., Christensen T.B., Berg T. Uptake and degradation of bovine testes β-galactosidase by parenchymal and nonparenchymal rat liver cells. Int. J. Biochem. 17:1985;1321-1328.
44. Mahato R.I., Takemura S., Akamatsu K., Nishikawa M., Takakura Y., Hashida M. Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine). Biochem. Pharmacol. 53:1997;887-895.